Teva Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,250,000,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | FTC | $1,200,000,000 |
Bank Hapoalim B.M. and Bank Hapoalim (Switzerland) Ltd. | Bank Hapoalim | financial services | tax violations | 2020 | DOJ_TAX | $616,910,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $512,000,000 |
Cephalon Inc | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | FDA | $425,000,000 |
Teva Pharmaceuticals, Ltd. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | NY-AG | $313,343,793 |
Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries | pharmaceuticals | Foreign Corrupt Practices Act | 2016 | DOJ_CRIMINAL | $283,177,348 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | FL-AG | $278,826,499 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
Bank Leumi Group | Bank Leumi | financial services | tax violations | 2014 | DOJ_TAX | $270,000,000 |
Teva Pharmaceuticals Industries Ltd. | Teva Pharmaceutical Industries | pharmaceuticals | product safety violation | 2012 | private lawsuit-federal | $270,000,000 |
Teva Pharmaceutical Industries Limited | Teva Pharmaceutical Industries | pharmaceuticals | Foreign Corrupt Practices Act | 2016 | SEC | $236,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | TX-AG | $225,000,000 |
Barr Laboratories Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-state | $225,000,000 |
Bank Hapoalim B.M. | Bank Hapoalim | financial services | tax violations | 2020 | NY-DFS | $220,000,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
Bank Leumi | Bank Leumi | financial services | tax violations | 2014 | NY-DFS | $130,000,000 |
Cephalon | Teva Pharmaceutical Industries | pharmaceuticals | consumer protection violation | 2016 | MULTI-AG | $125,000,000 |
Actavis Mid-Atlantic LLC | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $118,614,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | Controlled Substances Act violation | 2019 | OK-AG | $85,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | WV-AG | $83,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $79,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Teva Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2023 | KY-AG | $71,477,474 |
Actavis Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $71,000,000 |
Teva | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | MD-AG | $70,281,867 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | CA-AG | $69,000,000 |
Andrx Corporation | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $55,000,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2019 | private lawsuit-federal | $54,000,000 |
Watson Laboratories | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $48,000,000 |
Actavis Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $41,000,000 |
Andrx Corporation | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
Bank Hapoalim B.M, | Bank Hapoalim | financial services | tax violations | 2020 | FED | $37,350,000 |
Watson, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2018 | MS-AG | $33,408,547 |
Bank Hapoalim B.M. | Bank Hapoalim | financial services | anti-money-laundering deficiencies | 2020 | DOJ_CRIMINAL | $30,063,317 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
Teva Pharmaceuticals USA Inc. and IVAX LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2014 | DOJ_CIVIL | $27,600,000 |
Teva Parmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $27,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $27,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $24,000,000 |
Lion Oil Company | Delek | oil and gas | environmental violation | 2003 | EPA | $22,298,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | RI-AG | $21,000,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $19,900,000 |
El Al Israel Airlines Ltd. | El Al Israel Airline | airlines | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $15,800,000 |
EL AL Israel Airlines Ltd. | El Al Israel Airline | airlines | price-fixing or anti-competitive practices | 2009 | DOJ_ANTITRUST | $15,700,000 |
TEVA Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $14,000,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $13,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | kickbacks and bribery | 2014 | IL-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $12,100,000 |
Israel Discount Bank | Israel Discount Bank | financial services | anti-money-laundering deficiencies | 2006 | FINCEN | $12,000,000 |
Alpharma USPD, Inc. and Purepac Pharmaceutical Co. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $10,200,000 |
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | KY-AG | $10,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Israel Discount Bank of New York | Israel Discount Bank | financial services | anti-money-laundering deficiencies | 2005 | NY-MANDA | $8,500,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $8,200,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,500,000 |
Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
Teva Pharmaceuticals USA, Inc. et al. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $6,500,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | CT-AG | $6,150,000 |
Israel Discount Bank of New York | Israel Discount Bank | financial services | anti-money-laundering deficiencies | 2006 | NY-DFS | $6,000,000 |
Barr Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $5,400,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $3,600,000 |
Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $2,400,000 |
Delek Logistics Operating, LLC et al. | Delek | oil and gas | environmental violation | 2019 | EPA | $2,255,460 |
Delek Logistics Operating, LLC | Delek | oil and gas | environmental violation | 2019 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,255,460 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2013 | EPA | $2,250,000 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
Alpharma USPD, Inc., | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2007 | MA-AG | $2,000,000 |
Alon USA | Delek | oil and gas | environmental violation | 2019 | EPA | $1,956,250 |
Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
Anda | Teva Pharmaceutical Industries | pharmaceuticals | Controlled Substances Act violation | 2016 | WV-AG | $1,800,000 |
Watson Pharmaceuticals Inc. and Watson Pharma Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $1,700,000 |
Bank Leumi | Bank Leumi | financial services | investor protection violation | 2016 | SEC | $1,600,000 |
Teva Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | consumer protection violation | 2023 | KY-AG | $1,407,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,100,000 |
EL AL Israel Airlines Ltd. | El Al Israel Airline | airlines | aviation consumer protection violation | 2022 | ACPD | $900,000 |
Paramount Petroleum Corporation | Delek | oil and gas | environmental violation | 2008 | CA-SCAQMD | $850,000 |
Paramount Petroleum Corporation | Delek | oil and gas | environmental violation | 2004 | CA-SCAQMD | $750,000 |
Lion Oil Company | Delek | oil and gas | environmental violation | 2003 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $708,000 |
Alpharma USPD, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | ID-AG | $600,000 |
Alon USA, LP | Delek | oil and gas | environmental violation | 2014 | TX-ENV | $550,000 |
Lion Oil Company | Delek | oil and gas | environmental violation | 2013 | EPA | $504,000 |
DELEK TYLER REFINERY | Delek | oil and gas | environmental violation | 2014 | EPA | $475,000 |
Alon USA, LP | Delek | oil and gas | environmental violation | 2018 | EPA | $372,611 |
Alon USA, LP | Delek | oil and gas | environmental violation | 2018 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $372,611 |
Paramount Petroleum Corporation; Alon Supply, Inc. | Delek | oil and gas | environmental violation | 2018 | CA-ARB | $300,000 |
Delek Refining, Ltd. | Delek | oil and gas | environmental violation | 2007 | TX-ENV | $230,716 |
Paramount Petroleum Corporation | Delek | oil and gas | environmental violation | 2011 | CA-SCAQMD | $220,000 |
DELEK REFINING, LTD. | Delek | oil and gas | workplace safety or health violation | 2008 | OSHA | $217,350 |
Alon USA, LP | Delek | oil and gas | environmental violation | 2017 | EPA | $215,625 |
ALON USA LP | Delek | oil and gas | environmental violation | 2009 | PHMSA | $200,000 |